Form 4 holding
Chief Medical Officer
CRISPR Therapeutics AG
- Security class
- Common Shares
- Shares / value
- 4,411
- Estimated value
- $275,700
- Report date
- 24 May 2023
- Price
- $62.50
- Ownership
- Direct
Phuong Khanh Morrow - Chief Medical Officer at CRISPR Therapeutics AG
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- CRSP on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Phuong Khanh Morrow since 19 Aug 2025
Reported holdings for Phuong Khanh Morrow in CRISPR Therapeutics AG
Form 4 holding
Chief Medical Officer
CRISPR Therapeutics AG
- Security class
- Restricted Stock Units
- Shares / value
- 20,812
- Estimated value
- Report date
- 23 May 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
Form 4 holding
Chief Medical Officer
CRISPR Therapeutics AG
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 16,667
- Estimated value
- Report date
- 13 Oct 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
Transaction history for Phuong Khanh Morrow in CRISPR Therapeutics AG
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.